Metatron, Inc. (OTC Pink: MRNJ) Soars 200% After Announcing Development of Initial Coin Offering (ICO) App
Metatron, Inc. (OTC Pink: MRNJ) is engaged as a mobile app developer for cannabis, CBD, and other interests. Shares of the mobile app developer are skyrocketing 200%, through early trading on Wednesday, October 25, 2017. Over the past month, Metatron, Inc. has seen average daily volume of 27.46 million shares. However, volume of 1.5 billion shares or dollar volume of $450,000, has already exchanged hands on the day.
Shares of Metatron, Inc. are surging today, after the company announced that it is developing a cryptocurrency app that will track Initial Coin Offerings and their tokens. The company is even exploring developing its own CBD/Hemp-based coin, but due to regulatory uncertainty, the company is putting its own ICO on hold for now until further clarity. The company’s apps are available in the Google Play and Apple App Store. Here is the full press release detailing of the development of its ICO app:
Metatron, Inc. Press Release:
DOVER, DE / ACCESSWIRE / October 25, 2017 / Metatron, Inc. (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it has in development a crypto-currency based app that will track all the tokens and coins existing now and ones coming out in the near future.
Metatron is exploring a CBD/Hemp based coin and has laid the foundation for its release, but due to the unclear legal environment related to cryto- currency the company is in a holding pattern. In the meantime as the developer of over 2000+ apps with over $3.5M+USD in historical sales, the company is developing an app/portal that will track the prices and market conditions of current virtual coins and initial coin offerings.
“Cannabis and Crypto-Currencies like Bitcoin and Etherium will be some of the biggest dollar markets in history and we here at Metatron intend to be a part of these ever growing industries,” stated CEO Joe Riehl. Metatron is working with potential partners to expedite this move into the medical aspect of the Cannabis revolution that has established grow and extraction capabilities established and producing.
If you would like to submit questions to the Metatron CEO Joe Riehl and listen in on a live interview please tune into the popular Patricia Steere talk show today at 3pm PST.
Direct live link: http://bit.ly/metatronceo Download her app: http://apple.co/2gGQF2F
The company is also pleased to announce a formal offer to Buzzlink.com, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares.
Metatron approved investors can acquire Series B shares in blocks of various sizes starting at 1k and recently increased discounts. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares at a 60% discount. There are a limited number of B shares available and Metatron reserves the right to end offering at any time.
We would also like everyone to to a look at up and coming app http://wherewedrink.com a new app that will revolutionize the bar industry. Metatron does not currently have a financial interest in the app or company but likes to support the work of great local app developers. “Get on board early…this one will is a game-changer” states Joe Riehl.
Details available at
http://metatroninc.com/series- b/ or http://www.metatronstock.com.
Metatron’s Apps: iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc Facebook:http://www.facebook.com/metatroninc Twitter: http://twitter.com/metatroninc News: http://metatroninc.com/blog
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.
Latest posts by Matt Rego (see all)
- The Power of Cannabidiol (CBDs) and the Future of Wellness - December 15, 2017
- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) Climbs 47.12% After Announcing Publication in Science Magazine Detailing of Positive Animal Treatment Data For Retinal Damage - December 15, 2017
- Bayport International Holdings, Inc. (OTC Pink: BAYP) Releases Shareholder Update On Cannabis Technology Platforms - December 14, 2017